[PHNUTR-L] Canadian Class Action Launched Against the Manufacturer
Kathrynne Holden, MS, RD
fivestar at nutritionucanlivewith.com
Mon Jun 5 06:21:58 PDT 2006
Colleagues, the following is FYI and does not necessarily reflect my own
opinion. I have no further knowledge of the topic. If you do not wish to
receive these posts, set your email filter to filter out any messages
coming from @nutritionucanlivewith.com and the program will remove
anything coming from me.
Canadian Class Action Launched Against the Manufacturer of Seroquel
Dow Jones - Jun. 01, 2006
MONTREAL, June 1 /CNW Telbec/ - Mr. François-Luc Lavallée, a 48 year-old
citizen of Bois-des-Fillions, Québec, is the representative Plaintiff in
a national class action claiming more than $100,000,000 in damages and
interest on behalf of the entire plaintiff class from the multi-national
company AstraZeneca. Mr. Lavallee has issued a claim by way of a class
action on behalf of all citizens, in Canada, who took the antipsychotic
medication Seroquel(R). Seroquel(R) is prescribed for various mental
health problems such as schizophrenia and bi-polar disorder.
Mr. Lavallée alleges having developed, among other problems, Type II
diabetes after having used this medication and he alleges AstraZeneca
has failed to inform the public, health authorities and patients of the
serious health risks associated with this medication.
Seroquel(R) has been prescribed to more than 8 million people across the
globe. This drug is a sales leader in the atypical antipsychotic
pharmaceutical market in the United States and in Canada. The plaintiff
class is estimated at thousands of persons. Many legal actions have been
filed in the United States and in Canada, namely in Alberta, and British
Columbia alleging similar claims.
Mr. Lavallée is represented by Lauzon Bélanger, a prominent class action
firm in Canada, which works in close collaboration with McNally Cuming
Raymaker who represents claimants from Alberta, and British Columbia, as
well as Roy Elliott Kim O'Connor who represents class members in Ontario.
All persons interested by this class action request may consult the
complete text of the motion on Lauzon Bélanger's Web site at
www.lauzonbelanger.qc.ca or contact the firm's Member Services by e-mail
to serviceauxmembres at lauzonbelanger.qc.ca or by phone at 514-287-1000 or
For Ontario inquiries, please contact REKO LLP at www.reko.ca , by
e-mail to info at reko.ca or by phone at 416-362-1989.
In Western Canada, please contact McNally Cuming Raymaker, at
www.mcnallycuming.com, by e-mail to rfogel at mcnallycuming.com, or by
phone at 1-800-682-2480.
/CONTACT: Anna Vetere, director, Lauzon Bélanger inc., (514) 287-1000,
(END) Dow Jones Newswires
June 01, 2006 09:49 ET (13:49 GMT)
Kathrynne Holden, MS, RD < fivestar at nutritionucanlivewith.com >
"Ask the Parkinson Dietitian" http://www.parkinson.org/
"Eat well, stay well with Parkinson's disease"
"Parkinson's disease: Guidelines for Medical Nutrition Therapy"
More information about the PHNUTR-L